title: Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.
authors: Giulia
authors: G
authors: Cervetti
authors: Giovanni
authors: G
authors: Carulli
authors: Sara
authors: S
authors: Galimberti
authors: Antonio
authors: A
authors: Azzarà
authors: Gabriele
authors: G
authors: Buda
authors: Enrico
authors: E
authors: Orciuolo
authors: Matteo
authors: M
authors: Pelosini
authors: Mario
authors: M
authors: Petrini
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate